Latest Headlines

  1. Vivodyne Launches The World's Largest Human Biological Datacenter To Train The First World Model Of Human Biology 8/12/2026

    Vivodyne, the company making human biology computable at AI scale, today announced the world’s largest human biological datacenter, with 12 robotic HIVE laboratories and the annual capacity to perform controlled trials on 3.1 million large human tissues per year — estimated at twice the scale of every clinical trial in the USA combined.

  2. Amprion Partners With MLM Medical Labs To Expand Alpha-Synuclein SAA Testing In Europe 8/12/2026

    Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a strategic licensing collaboration with MLM Medical Labs, a global central and specialty laboratory with operations in Germany.

  3. NIAID Awards Zepto Life Technology Contract Valued At Up To $8.9M To Advance The First Deployable Liquid Biopsy Platform For Infectious Disease 8/11/2026

    Zepto Life Technology today announced that it has been awarded a contract valued at up to $8.9 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to advance its plasma cell-free DNA liquid biopsy platform for invasive fungal infections.

  4. Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software 8/11/2026

    Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances that strengthen its connected clinical digital pathology portfolio, including the industry's first standalone, AI-assisted quality control software.

  5. A Blood Test Can Provide More Information About Cancer 8/11/2026

    A single blood test could in future provide a more comprehensive picture of cancer than current methods. In a review article published in the journal Genome Medicine, researchers at Karolinska Institutet describe how several different biological signals can be analysed simultaneously from the same blood sample to detect and monitor cancer diseases.

  6. Bruker Announces Strategic Collaboration With Atinary Technologies To Advance Self-Driving Laboratories 8/11/2026

    Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary.

  7. Labcorp Announces FDA Approval Of Companion Diagnostic Supporting Patients With Advanced Melanoma 8/10/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that the U.S. Food and Drug Administration (FDA) has approved Labcorp's PGDx elio® tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF variants who may benefit from treatment with FDA-approved targeted therapiesi.

  8. ECI's Product & Packaging Testing Laboratory Achieves ISO/IEC 17025 Accreditation 8/10/2026

    ECI announced today that its Product & Packaging Testing Laboratory, located in the Coyol Free Zone in Costa Rica, has achieved ISO/IEC 17025:2017 accreditation from A2LA for technical competence in mechanical testing.

  9. Blood Test Could Speed Lymphoma Diagnosis In Resource-Limited Settings 8/7/2026

    For people with lymphoma, getting the right diagnosis can be a race against time.

  10. GSI Group Expands Platform With Acquisition Of Aven Tools 8/6/2026

    GSI Group Holdings ("GSI Group") announces it has acquired Aven Tools, a leading designer and manufacturer of proprietary precision tools, instruments, and accessories.